Loading...
XESMUPR
Market cap569mUSD
Dec 20, Last price  
2.00EUR
1D
-2.44%
1Q
-23.08%
IPO
70.94%
Name

Uniphar PLC

Chart & Performance

D1W1MN
XESM:UPR chart
P/E
12.18
P/S
0.21
EPS
0.16
Div Yield, %
0.88%
Shrs. gr., 5y
18.06%
Rev. gr., 5y
10.47%
Revenues
2.55b
+23.30%
639,639,000860,495,0001,128,759,0001,117,248,0001,296,320,0001,267,418,0001,552,100,0001,665,283,0001,823,854,0001,943,149,0002,070,669,0002,553,062,000
Net income
45m
-1.69%
-4,583,000-17,854,000-19,481,0005,946,0005,738,000-1,028,00017,300,00021,026,00027,827,00048,077,00045,587,00044,815,000
CFO
53m
-36.60%
13,034,00014,273,00014,720,00025,999,00023,697,000-1,683,000-8,738,000106,997,00065,978,00052,177,00082,831,00052,511,000
Dividend
Sep 12, 20240.0067 EUR/sh
Earnings
Feb 25, 2025

Profile

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, and internationally. The company operates through three divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers; and distribution and support services to medical device manufacturers. The Product Access division provides on demand services, which provides access to pharmaco-medical products and treatments by developing valuable relationships and interactions between manufacturers and other healthcare stakeholders; and exclusive access services that offers bespoke distribution partnerships to pharmaceutical partners for key brands. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons; and operates a network of pharmacies under the Life, Allcare, and Hickey's brands. It also offers pharmacy support, pharmaceutical supply chain, specialist nursing and infusion, medical device distribution, healthcare technology, data intelligence and consultancy services, pharmaceutical advisory, medical affairs, and online pharmacy and product fostering services, as well as data solutions for pharma industry. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.
URL
https://www.uniphar.ie/
IPO date
Jul 17, 2019
Employees
2,800
Domiciled in
IE
Incorporated in
IE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
2,553,062
23.30%
2,070,669
6.56%
1,943,149
6.54%
Cost of revenue
2,476,260
2,018,580
1,884,076
Unusual Expense (Income)
NOPBT
76,802
52,089
59,073
NOPBT Margin
3.01%
2.52%
3.04%
Operating Taxes
7,750
8,970
7,679
Tax Rate
10.09%
17.22%
13.00%
NOPAT
69,052
43,119
51,394
Net income
44,815
-1.69%
45,587
-5.18%
48,077
72.77%
Dividends
(4,832)
(4,666)
(5,731)
Dividend yield
0.66%
0.55%
0.42%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
33,302
21,805
16,079
Long-term debt
494,904
413,584
348,399
Deferred revenue
Other long-term liabilities
33,290
94,060
90,401
Net debt
442,529
331,660
286,428
Cash flow
Cash from operating activities
52,511
82,831
52,177
CAPEX
(21,258)
(19,921)
(14,429)
Cash from investing activities
(90,428)
(106,332)
(49,658)
Cash from financing activities
19,630
50,405
13,259
FCF
91,511
(38,661)
39,687
Balance
Cash
85,652
103,704
78,025
Long term investments
25
25
25
Excess cash
196
Stockholders' equity
150,872
113,282
75,063
Invested Capital
748,899
694,212
582,915
ROIC
9.57%
6.75%
9.48%
ROCE
10.26%
7.50%
10.13%
EV
Common stock shares outstanding
273,015
272,557
269,752
Price
2.70
-12.90%
3.10
-38.00%
5.00
110.08%
Market cap
737,140
-12.76%
844,927
-37.36%
1,348,760
115.94%
EV
1,180,488
1,176,826
1,635,308
EBITDA
112,208
80,559
86,003
EV/EBITDA
10.52
14.61
19.01
Interest
22,083
9,290
6,926
Interest/NOPBT
28.75%
17.83%
11.72%